The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I or pharmaceutically acceptable salts thereof. Formula I or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds in the treatment of Btk mediated disorders.
本发明提供了布鲁顿
酪氨酸激酶(Btk)
抑制剂化合物,该化合物符合公式I或其药用可接受的盐。公式I或其药用可接受的盐,或包含这些化合物的药物组合物及其在治疗中的用途。特别是,本发明涉及在治疗Btk介导的疾病中使用Btk
抑制剂化合物。